Breaking

Allied Critical Metals Announces $4 Million Strategic Non-Brokered Private Placement
Crypto Market Update: ARK Picks Canadian Staking Partner, PayPal Unveils New Service
Torex to Acquire Prime Mining in US$449 Million Deal, Expands Mexican Gold-Silver Portfolio
Nickel Price Update: Q2 2025 in Review
Peter Grandich: Copper, Uranium in “Perfect Storm,” My Strategy Now
Elon Musk confirms Tesla has signed a $16.5 billion chip contract with Samsung Electronics
US judge blocks Trump effort to cut Planned Parenthood funding
Key Trump nominees stalled by Senate Dems puts pressure on GOP leaders

Politics
Business
World
Investing
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Crypto Market Update: ARK Picks Canadian Staking Partner, PayPal Unveils New Service

Allied Critical Metals Announces $4 Million Strategic Non-Brokered Private Placement

Torex to Acquire Prime Mining in US$449 Million Deal, Expands Mexican Gold-Silver Portfolio

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,763)
- Investing (5,569)
- Politics (8,592)
- Uncategorized (3)
- World (6,632)

Disclaimer: usaandshares.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2023 usaandshares.com | All Rights Reserved

Top

Politics
Business
World
Investing

Type above and press Enter to search. Press Esc to cancel.